BioVendor R D

首页 产品目录(简版) 公司动态 企业认证 联系我们

Clear trends: NGS is in demand

发布人:BioVendor R D

发布日期:2025/3/11 14:25:37

Anna Kolouchová, Business Development Manager at BioVendor MDx, presented this technology in Dubai: “This year, we focused on presenting our NGS solutions in oncology. The professional community’s interest in genetic testing of somatic mutations and their data analysis continues to grow, which was evident in the number of meetings with potential distributors and the valuable feedback from our booth visitors.” Compared to last year, it was clear that the trade fair is continuously evolving and expanding.

相关新闻资讯

BioVendor Group partners with healthcare focused investment firm ARCHIMED

2025/03/11

10. 3. 2025 ARCHIMED is a global investment firm specialising in the healthcare industries, with biotechnology and diagnostics being among the core investment areas. With an international presence,

Clear trends: NGS is in demand

2025/03/11

Anna Kolouchová, Business Development Manager at BioVendor MDx, presented this technology in Dubai: “This year, we focused on presenting our NGS solutions in oncology. The professional community’s